Literature DB >> 25610266

CT- and Fluoroscopy-Guided Percutaneous Transabdominal Embolization of Type II Endoleak.

Kutlay Karaman1, A Murat Dokdok1, Oktay Karadeniz1.   

Abstract

We report a case of a 79-year-old male patient who was treated 3 years previously at another hospital for an abdominal aortic aneurysm with a maximal diameter of 80 mm. After the treatment control period, computed tomography imaging revealed a type II endoleak and no progression in the size of the aneurysm sac. Selective injection of the superior mesenteric artery revealed that the endoleak was filled by the inferior mesenteric artery via the marginal artery. However, it was not possible to access using retrograde catheterization. We decided to treat the type II endoleak percutaneously. Embolization was performed at the tomography table using fluoroscopy with a mobile C-arm, and the puncture was performed transabdominally because there was no access to the sac via a translumbar approach. Under fluoroscopic guidance, various diameter/length coils were deployed. Follow-up computed tomography scans confirmed the collapsed aneurysm sac. When other conventional endovascular methods have failed, percutaneous transabdominal treatment of a type II endoleak with sac enlargement offers an alternative treatment method.

Entities:  

Keywords:  Abdominal aortic aneurysm; embolization; type II endoleak

Year:  2013        PMID: 25610266      PMCID: PMC4261490          DOI: 10.5152/eajm.2013.26

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  8 in total

1.  Retroperitoneal endoscopic ligation of lumbar and inferior mesenteric arteries as a treatment of persistent endoleak after endoluminal aortic aneurysm repair.

Authors:  W Wisselink; M A Cuesta; F J Berends; F G van den Berg; J A Rauwerda
Journal:  J Vasc Surg       Date:  2000-06       Impact factor: 4.268

2.  Treatment of type II endoleaks with Onyx.

Authors:  M L Martin; B L Dolmatch; P D Fry; L S Machan
Journal:  J Vasc Interv Radiol       Date:  2001-05       Impact factor: 3.464

3.  The use of direct thrombin injection to treat a type II endoleak following endovascular repair of abdominal aortic aneurysm.

Authors:  Peter K Ellis; Peter T Kennedy; Anton J Collins; Paul H Blair
Journal:  Cardiovasc Intervent Radiol       Date:  2003 Sep-Oct       Impact factor: 2.740

4.  Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: comparison of transarterial and translumbar techniques.

Authors:  Richard A Baum; Jeffrey P Carpenter; Michael A Golden; Omaida C Velazquez; Timothy W I Clark; S William Stavropoulos; Constantine Cope; Ronald M Fairman; S Willliam Stavropoulous
Journal:  J Vasc Surg       Date:  2002-01       Impact factor: 4.268

5.  Inferior mesenteric artery embolization before endovascular repair of an abdominal aortic aneurysm: effect on type II endoleak and aneurysm shrinkage.

Authors:  Terhi Nevala; Fausto Biancari; Hannu Manninen; Pekka Matsi; Kimmo Mäkinen; Kari Ylönen; Jukka Perälä
Journal:  J Vasc Interv Radiol       Date:  2009-12-21       Impact factor: 3.464

6.  Treatment of type II endoleaks after endovascular repair of abdominal aortic aneurysms: transcaval approach.

Authors:  Giancarlo Mansueto; Daniela Cenzi; Mirko D'Onofrio; Enrico Petrella; Andrew A Gumbs; Roberto Pozzi Mucelli
Journal:  Cardiovasc Intervent Radiol       Date:  2005 Sep-Oct       Impact factor: 2.740

7.  Type 2 endoleak embolization comparison: translumbar embolization versus modified transarterial embolization.

Authors:  S William Stavropoulos; Jin Park; Ronald Fairman; Jeffrey Carpenter
Journal:  J Vasc Interv Radiol       Date:  2009-08-19       Impact factor: 3.464

8.  Type II endoleak after endovascular repair of abdominal aortic aneurysm: effectiveness of embolization.

Authors:  Terhi Nevala; Fausto Biancari; Hannu Manninen; Pekka-Sakari Aho; Pekka Matsi; Kimmo Mäkinen; Wolf-Dieter Roth; Kari Ylönen; Mauri Lepäntalo; Jukka Perälä
Journal:  Cardiovasc Intervent Radiol       Date:  2009-08-18       Impact factor: 2.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.